Heart of the Matter White Papers

McCann Complete Medical: The Heart of the Matter white paper series

Please fill out the form below to have this white papers emailed to you.

HTM_2_Tweet

Heart of the Matter: To tweet or not to tweet — is that still a question?

Communication models have moved on – so why are parts of the pharmaceuticals industry stuck in the dark ages when it comes to adopting a truly multichannel approach in the pre-launch phase? All that Twitters is not gold, but it isn’t pyrite either.

We’ve come a long way since the days of Shakespeare. These days, whether it’s theater or communications, the stage is open to anyone, and the audience doesn’t even have to leave home. All the world’s a stage. So where does the drug industry feature in the global playhouse of multichannel communications? It’s barely reached the end of Act I.

HTM_1_Ethics

Heart of the Matter: The only way is ethics

How an upsurge in compliance focus, anti-bribery measures, and a drive to greater transparency are leading pharma towards partners with demonstrable compliance capability and infrastructure.
Compliance is a powerful term with seemingly paradoxical implications; it can keep businesses awake at night and, as compliance training and administration reach overload, send employees to sleep during the day. But pharmaceutical executives who fail to understand the full extent of their compliance obligations could be sleepwalking their way towards major reputational damage.